`

VBL Therapeutics (Nasdaq:VBLT)

Biotechnology Research

Specialities :
Biotech / pharma
Innovation
And immune-inflammatory
Sign Up to View More
revenue-icon Revenue
< 1M
funding-icon Total Funding
--
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About VBL Therapeutics (Nasdaq:VBLT)

What does Vbl therapeutics (nasdaq:vblt) do?+

VBL Therapeutics (Nasdaq: VBLT) is developing targeted therapies for immune-inflammatory diseases. VBLs lead immunology product candidate VB-601 is a targeted antibody for immune-inflammatory applications expected to enter Phase 1 this year that has shown disease-modifying activity across multiple preclinical models including multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease

What are Vbl therapeutics (nasdaq:vblt)'s specialties? +

Biotech / pharma,innovation,and immune-inflammatory

What is Vbl therapeutics (nasdaq:vblt)'s industry? +

Vbl therapeutics (nasdaq:vblt) operates in the Biotechnology research industry.

What is Vbl therapeutics (nasdaq:vblt)'s revenue? +

Vbl therapeutics (nasdaq:vblt)'s revenue is < 1m

What is Vbl therapeutics (nasdaq:vblt)'s company size? +

Vbl therapeutics (nasdaq:vblt) has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free